Chun-Tao Wu
Overview
Explore the profile of Chun-Tao Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
805
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang L, Liu Y, Wu C, Ni C, Liu Y
BMJ Open
. 2023 Jan;
12(6):e052469.
PMID: 36691232
Introduction: Currently, various guidelines and documents on the prevention of pressure injuries have been published, but there are many serious lags in the actual practice in nursing homes. So some...
2.
Xu S, Li H, Li T, Li S, Xia H, Long J, et al.
Front Immunol
. 2021 Jun;
12:577517.
PMID: 34084158
Background: Extracellular traps (ETs) and tumor-infiltrating immune cells can contribute to disease progression. The clinical significance of tumor-infiltrating neutrophils and macrophages and related extracellular traps in pancreatic neuroendocrine tumors (pNETs)...
3.
Wang W, Zhang W, Gao H, Huang D, Xu H, Li S, et al.
J Gastroenterol
. 2021 Mar;
56(4):395-405.
PMID: 33742253
Background: Pancreatic neuroendocrine tumors (PanNETs) are indolent pancreatic tumors derived from neuroendocrine cells in pancreatic islets. To date, reliable predictors for identifying patients at high risk for recurrence after curative...
4.
Jin Y, Yang W, Sun Z, Wang Z, Chen J, Wu C, et al.
Medicine (Baltimore)
. 2021 Mar;
100(10):e24979.
PMID: 33725867
Rationale: Advanced signet ring cell (SRC) carcinoma has a worse prognosis. Therefore, early diagnosis and prevention is particularly important; SRC tumors have lower R0 resection rate and are thought to...
5.
Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspective
Zhang W, Wang W, Han X, Gao H, Li T, Xu S, et al.
Comput Struct Biotechnol J
. 2020 Dec;
18:3606-3614.
PMID: 33304458
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy that is usually diagnosed at an advanced stage when curative surgery is no longer an option. Robust diagnostic biomarkers with high sensitivity...
6.
Li T, Li H, Zhang W, Xu S, Jiang W, Li S, et al.
Int J Cancer
. 2020 Nov;
148(7):1756-1767.
PMID: 33236361
Splenectomy is routinely performed during distal or total pancreatectomy (DP or TP) for pancreatic ductal adenocarcinoma (PDAC), but information about its oncological value is limited. TER cells, nonimmune cells discovered...
7.
Jin Y, Yang W, Zou S, Sun Z, Wu C, Yang Z
Medicine (Baltimore)
. 2020 Oct;
99(43):e22785.
PMID: 33120792
Rationale: Nasopharyngeal carcinoma (NPC) is one of the most common malignancies in Southern China. Although combined chemotherapy with radiotherapy has been widely used in treating locally advanced lesions, relapse and...
8.
Zhang W, Wang W, Han X, Gao H, Xu S, Li S, et al.
J Immunother Cancer
. 2020 Oct;
8(2).
PMID: 33055204
Background: Tertiary lymphoid structures (TLS) are associated with favorable survival and play a critical role in most solid tumors. However, investigations of TLS are lacking in patients with grade 1...
9.
Gao H, Wang W, Xu H, Wu C, Li H, Ni Q, et al.
World J Clin Cases
. 2020 Sep;
8(17):3751-3762.
PMID: 32953851
Background: Pancreatic neuroendocrine tumors (PanNETs) are heterogeneous and indolent; systemic therapy is not essential for every patient with metastatic PanNET. The National Comprehensive Cancer Network guidelines state that delaying treatment...
10.
Li H, Jiang W, Liu X, Yuan L, Li T, Li S, et al.
Oncogene
. 2020 Aug;
39(36):5825-5838.
PMID: 32753651
Chemoresistance is a major obstacle to prolonging pancreatic ductal adenocarcinoma (PDAC) patient survival. TET1 is identified as the most important epigenetic modification enzyme that facilitates chemoresistance in cancers. However, the...